Fig. 3 | Scientific Reports

Fig. 3

From: Development, verification, and comparison of a risk stratification model to identify potential population benefiting from chemotherapy in non-metastatic male breast cancer

Fig. 3

Validation of the proposed nomogram. (A,B) ROC curves for predicting the overall survival in the training and validation cohorts at 3-year, 5-year, and 10-year, respectively. (C,D) the time-dependent AUC values of nomogram in the training cohort and validation cohort. (E,F) the calibration curves for predicting patients’ overall survival in the training and validation cohorts at 3-year, 5-year, and 10-year, respectively.

Back to article page